SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Heron Therapeutics, Inc./DE – ‘10-Q’ for 3/31/13 – ‘EX-101.PRE’

On:  Friday, 5/10/13, at 2:34pm ET   ·   For:  3/31/13   ·   Accession #:  1193125-13-213597   ·   File #:  1-33221

Previous ‘10-Q’:  ‘10-Q’ on 11/5/12 for 9/30/12   ·   Next:  ‘10-Q’ on 8/8/13 for 6/30/13   ·   Latest:  ‘10-Q’ on 5/7/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/10/13  Heron Therapeutics, Inc./DE       10-Q        3/31/13   45:1.7M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    164K 
 2: EX-10.AI    Material Contract                                   HTML     81K 
 3: EX-10.AJ    Material Contract                                   HTML     84K 
 4: EX-10.AK    Material Contract                                   HTML     81K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     16K 
28: R1          Document and Entity Information                     HTML     41K 
21: R2          Condensed Balance Sheets                            HTML     69K 
26: R3          Condensed Statements of Operations (Unaudited)      HTML     56K 
30: R4          Condensed Statements of Cash Flows (Unaudited)      HTML     87K 
41: R5          Business and Basis of Presentation                  HTML     25K 
22: R6          Cash Equivalents                                    HTML     21K 
25: R7          Fair Value Measurements                             HTML     26K 
20: R8          Net Loss Per Share                                  HTML     22K 
16: R9          Stock-Based Compensation                            HTML     29K 
42: R10         Comprehensive Loss                                  HTML     21K 
32: R11         Discontinued Operations                             HTML     27K 
31: R12         Convertible Notes to Related Parties                HTML     25K 
36: R13         Stockholders' Equity                                HTML     36K 
37: R14         Subsequent Event                                    HTML     17K 
35: R15         Business and Basis of Presentation (Policies)       HTML     37K 
38: R16         Net Loss Per Share (Tables)                         HTML     20K 
27: R17         Stock-Based Compensation (Tables)                   HTML     31K 
29: R18         Discontinued Operations (Tables)                    HTML     19K 
34: R19         NET LOSS PER SHARE - Outstanding potentially        HTML     24K 
                dilutive options, warrants and convertible notes                 
                (Details)                                                        
45: R20         STOCK-BASED COMPENSATION - Stock-based              HTML     31K 
                compensation expense (Details)                                   
39: R21         STOCK-BASED COMPENSATION - Stock option activity    HTML     44K 
                (Details)                                                        
23: R22         DISCONTINUED OPERATIONS - Loss from discontinued    HTML     15K 
                operations (Details)                                             
33: R23         Business and Basis of Presentation (Details         HTML     35K 
                Narrative)                                                       
24: R24         Stock-Based Compensation (Details Narrative)        HTML     19K 
15: R25         Comprehensive Loss (Details Narrative)              HTML     20K 
40: R26         Discontinued Operations (Details Narrative)         HTML     21K 
43: R27         Convertible Notes to Related Parties (Details       HTML     76K 
                Narrative)                                                       
18: R28         Stockholders' Equity (Details Narrative)            HTML     60K 
44: XML         IDEA XML File -- Filing Summary                      XML     56K 
17: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    155K 
 9: EX-101.INS  XBRL Instance -- appa-20130331                       XML    241K 
11: EX-101.CAL  XBRL Calculations -- appa-20130331_cal               XML     71K 
12: EX-101.DEF  XBRL Definitions -- appa-20130331_def                XML    143K 
13: EX-101.LAB  XBRL Labels -- appa-20130331_lab                     XML    306K 
14: EX-101.PRE  XBRL Presentations -- appa-20130331_pre              XML    261K 
10: EX-101.SCH  XBRL Schema -- appa-20130331                         XSD     70K 
19: ZIP         XBRL Zipped Folder -- 0001193125-13-213597-xbrl      Zip     44K

‘EX-101.PRE’   —   XBRL Presentations — appa-20130331_pre

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 3.4e -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: f10q_appa20130331.xfr; Date: 2013/05/10T16:47:59 -->
<!-- Field: Doc-Info; Name: Status; Value: 0x80000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://appharma.com/role/DocumentAndEntityInformation" xlink:href="appa-20130331.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/BalanceSheets" xlink:href="appa-20130331.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/StatementsOfOperations" xlink:href="appa-20130331.xsd#StatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/StatementsOfCashFlows" xlink:href="appa-20130331.xsd#StatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/BusinessAndBasisOfPresentation" xlink:href="appa-20130331.xsd#BusinessAndBasisOfPresentation" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/CashEquivalents" xlink:href="appa-20130331.xsd#CashEquivalents" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/FairValueMeasurements" xlink:href="appa-20130331.xsd#FairValueMeasurements" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/NetLossPerShare" xlink:href="appa-20130331.xsd#NetLossPerShare" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/Stock-BasedCompensation" xlink:href="appa-20130331.xsd#Stock-BasedCompensation" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/ComprehensiveLoss" xlink:href="appa-20130331.xsd#ComprehensiveLoss" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/DiscontinuedOperations" xlink:href="appa-20130331.xsd#DiscontinuedOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/ConvertibleNotesToRelatedParties" xlink:href="appa-20130331.xsd#ConvertibleNotesToRelatedParties" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/StockholdersEquity" xlink:href="appa-20130331.xsd#StockholdersEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/SubsequentEvent" xlink:href="appa-20130331.xsd#SubsequentEvent" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/BusinessAndBasisOfPresentationPolicies" xlink:href="appa-20130331.xsd#BusinessAndBasisOfPresentationPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/NetLossPerShareTables" xlink:href="appa-20130331.xsd#NetLossPerShareTables" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/Stock-BasedCompensationTables" xlink:href="appa-20130331.xsd#Stock-BasedCompensationTables" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/DiscontinuedOperationsTables" xlink:href="appa-20130331.xsd#DiscontinuedOperationsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/NetLossPerShare-OutstandingPotentiallyDilutiveOptionsWarrantsAndConvertibleNotesDetails" xlink:href="appa-20130331.xsd#NetLossPerShare-OutstandingPotentiallyDilutiveOptionsWarrantsAndConvertibleNotesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/Stock-BasedCompensation-Stock-BasedCompensationExpenseDetails" xlink:href="appa-20130331.xsd#Stock-BasedCompensation-Stock-BasedCompensationExpenseDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/Stock-BasedCompensation-StockOptionActivityDetails" xlink:href="appa-20130331.xsd#Stock-BasedCompensation-StockOptionActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/DiscontinuedOperations-LossFromDiscontinuedOperationsDetails" xlink:href="appa-20130331.xsd#DiscontinuedOperations-LossFromDiscontinuedOperationsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/BusinessAndBasisOfPresentationDetailsNarrative" xlink:href="appa-20130331.xsd#BusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/Stock-BasedCompensationDetailsNarrative" xlink:href="appa-20130331.xsd#Stock-BasedCompensationDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/ComprehensiveLossDetailsNarrative" xlink:href="appa-20130331.xsd#ComprehensiveLossDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="appa-20130331.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/ConvertibleNotesToRelatedPartiesDetailsNarrative" xlink:href="appa-20130331.xsd#ConvertibleNotesToRelatedPartiesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://appharma.com/role/StockholdersEquityDetailsNarrative" xlink:href="appa-20130331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple"/>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/DocumentAndEntityInformation" xlink:title="0001 - Document - Document and Entity Information">
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_DocumentAndEntityInformationAbstract" xlink:label="loc_APPADocumentAndEntityInformationAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_APPAEntityRegistrantName"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityRegistrantName" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_APPAEntityCentralIndexKey"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityCentralIndexKey" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType" xlink:label="loc_APPADocumentType"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPADocumentType" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_APPADocumentPeriodEndDate"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPADocumentPeriodEndDate" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_APPAAmendmentFlag"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAAmendmentFlag" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_APPACurrentFiscalYearEndDate"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPACurrentFiscalYearEndDate" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_APPAEntityWellKnownSeasonedIssuer"/>
<link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityWellKnownSeasonedIssuer" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_APPAEntityVoluntaryFilers"/>
<link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityVoluntaryFilers" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_APPAEntityCurrentReportingStatus"/>
<link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityCurrentReportingStatus" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_APPAEntityFilerCategory"/>
<link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityFilerCategory" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_APPAEntityPublicFloat"/>
<link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityPublicFloat" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_APPAEntityCommonStockSharesOutstanding"/>
<link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPAEntityCommonStockSharesOutstanding" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_APPADocumentFiscalPeriodFocus"/>
<link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPADocumentFiscalPeriodFocus" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_APPADocumentFiscalYearFocus"/>
<link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADocumentAndEntityInformationAbstract" xlink:to="loc_APPADocumentFiscalYearFocus" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/BalanceSheets" xlink:title="0002 - Statement - Condensed Balance Sheets">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_APPAStatementOfFinancialPositionAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_APPAAssetsAbstract"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementOfFinancialPositionAbstract" xlink:to="loc_APPAAssetsAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_APPAAssetsCurrentAbstract"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAssetsAbstract" xlink:to="loc_APPAAssetsCurrentAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_APPACashAndCashEquivalentsAtCarryingValue"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAssetsCurrentAbstract" xlink:to="loc_APPACashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_APPAPrepaidExpenseAndOtherAssetsCurrent"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAssetsCurrentAbstract" xlink:to="loc_APPAPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_APPAAssetsCurrent"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAssetsCurrentAbstract" xlink:to="loc_APPAAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_APPAPropertyPlantAndEquipmentNet"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAssetsAbstract" xlink:to="loc_APPAPropertyPlantAndEquipmentNet" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_APPAOtherAssetsNoncurrent"/>
<link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAssetsAbstract" xlink:to="loc_APPAOtherAssetsNoncurrent" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:label="loc_APPAAssets"/>
<link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAssetsAbstract" xlink:to="loc_APPAAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_APPALiabilitiesAndStockholdersEquityAbstract"/>
<link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementOfFinancialPositionAbstract" xlink:to="loc_APPALiabilitiesAndStockholdersEquityAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_APPAAccruedLiabilitiesCurrentAbstract"/>
<link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPALiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_APPAAccruedLiabilitiesCurrentAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_APPAAccountsPayableCurrent"/>
<link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccruedLiabilitiesCurrentAbstract" xlink:to="loc_APPAAccountsPayableCurrent" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_APPAAccruedLiabilitiesCurrent"/>
<link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccruedLiabilitiesCurrentAbstract" xlink:to="loc_APPAAccruedLiabilitiesCurrent" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:label="loc_APPAConvertibleNotesPayableRelatedPartiesCurrent"/>
<link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccruedLiabilitiesCurrentAbstract" xlink:to="loc_APPAConvertibleNotesPayableRelatedPartiesCurrent" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_APPALiabilitiesCurrent"/>
<link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccruedLiabilitiesCurrentAbstract" xlink:to="loc_APPALiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_APPAStockholdersEquityAbstract"/>
<link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementOfFinancialPositionAbstract" xlink:to="loc_APPAStockholdersEquityAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_APPACommonStockValue"/>
<link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStockholdersEquityAbstract" xlink:to="loc_APPACommonStockValue" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_APPAAdditionalPaidInCapital"/>
<link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStockholdersEquityAbstract" xlink:to="loc_APPAAdditionalPaidInCapital" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_APPARetainedEarningsAccumulatedDeficit"/>
<link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStockholdersEquityAbstract" xlink:to="loc_APPARetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_APPAStockholdersEquity"/>
<link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStockholdersEquityAbstract" xlink:to="loc_APPAStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_APPALiabilitiesAndStockholdersEquity"/>
<link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStockholdersEquityAbstract" xlink:to="loc_APPALiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/StatementsOfOperations" xlink:title="0003 - Statement - Condensed Statements of Operations (Unaudited)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_APPAIncomeStatementAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_APPAOperatingExpensesAbstract"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementAbstract" xlink:to="loc_APPAOperatingExpensesAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_APPAResearchAndDevelopmentExpense"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAOperatingExpensesAbstract" xlink:to="loc_APPAResearchAndDevelopmentExpense" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_APPAGeneralAndAdministrativeExpense"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAOperatingExpensesAbstract" xlink:to="loc_APPAGeneralAndAdministrativeExpense" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_APPAOperatingExpenses"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAOperatingExpensesAbstract" xlink:to="loc_APPAOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_APPAOperatingIncomeLoss"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementAbstract" xlink:to="loc_APPAOperatingIncomeLoss" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_APPAInterestIncomeExpenseNonoperatingNet"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementAbstract" xlink:to="loc_APPAInterestIncomeExpenseNonoperatingNet" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_APPAIncomeLossFromContinuingOperations"/>
<link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementAbstract" xlink:to="loc_APPAIncomeLossFromContinuingOperations" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_APPAIncomeLossFromDiscontinuedOperationsNetOfTax"/>
<link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementAbstract" xlink:to="loc_APPAIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_APPANetIncomeLoss"/>
<link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementAbstract" xlink:to="loc_APPANetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_APPAEarningsPerShareBasicAndDilutedAbstract"/>
<link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementAbstract" xlink:to="loc_APPAEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="loc_APPAIncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
<link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_APPAIncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_APPAEarningsPerShareBasicAndDiluted"/>
<link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_APPAEarningsPerShareBasicAndDiluted" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_APPAWeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_APPAWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/StatementsOfCashFlows" xlink:title="0004 - Statement - Condensed Statements of Cash Flows (Unaudited)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_APPAStatementOfCashFlowsAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_APPANetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementOfCashFlowsAbstract" xlink:to="loc_APPANetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_APPANetIncomeLoss"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPANetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_APPAAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPAAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_APPAIncomeLossFromDiscontinuedOperationsNetOfTax"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPAIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_APPADepreciationAndAmortization"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPADepreciationAndAmortization" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_APPAShareBasedCompensation"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPAShareBasedCompensation" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_APPAAmortizationOfDebtDiscountPremium"/>
<link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPAAmortizationOfDebtDiscountPremium" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_APPAIncreaseDecreaseInOperatingCapitalAbstract"/>
<link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPAIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_APPAIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_APPAIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_APPAIncreaseDecreaseInAccountsPayable"/>
<link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_APPAIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_APPAIncreaseDecreaseInAccruedLiabilities"/>
<link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_APPAIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_APPANetCashProvidedByUsedInOperatingActivities"/>
<link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_APPANetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_APPANetCashProvidedByUsedInInvestingActivitiesAbstract"/>
<link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementOfCashFlowsAbstract" xlink:to="loc_APPANetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_APPAPaymentsToAcquirePropertyPlantAndEquipment"/>
<link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_APPAPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_APPANetCashProvidedByUsedInInvestingActivities"/>
<link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_APPANetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementOfCashFlowsAbstract" xlink:to="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_APPAProceedsFromWarrantExercises"/>
<link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_APPAProceedsFromWarrantExercises" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_APPAProceedsFromStockOptionsExercised"/>
<link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_APPAProceedsFromStockOptionsExercised" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_APPANetCashProvidedByUsedInFinancingActivities"/>
<link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_APPANetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_APPACashAndCashEquivalentsPeriodIncreaseDecrease"/>
<link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_APPACashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_APPACashAndCashEquivalentsAtCarryingValue"/>
<link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_APPACashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_APPACashAndCashEquivalentsAtCarryingValue_2"/>
<link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPANetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_APPACashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/BusinessAndBasisOfPresentation" xlink:title="0005 - Disclosure - BUSINESS AND BASIS OF PRESENTATION">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_APPAAccountingPoliciesAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_APPABusinessDescriptionAndBasisOfPresentationTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPABusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/CashEquivalents" xlink:title="0006 - Disclosure - CASH EQUIVALENTS">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_APPACashAndCashEquivalentsAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="loc_APPACashAndCashEquivalentsDisclosureTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPACashAndCashEquivalentsAbstract" xlink:to="loc_APPACashAndCashEquivalentsDisclosureTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/FairValueMeasurements" xlink:title="0007 - Disclosure - FAIR VALUE MEASUREMENTS">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_APPAFairValueDisclosuresAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_APPAFairValueDisclosuresTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueDisclosuresAbstract" xlink:to="loc_APPAFairValueDisclosuresTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/NetLossPerShare" xlink:title="0008 - Disclosure - NET LOSS PER SHARE">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_APPAEarningsPerShareAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_APPAEarningsPerShareTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareAbstract" xlink:to="loc_APPAEarningsPerShareTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/Stock-BasedCompensation" xlink:title="0009 - Disclosure - STOCK-BASED COMPENSATION">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_APPAShareholdersEquityAndShareBasedPaymentsTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/ComprehensiveLoss" xlink:title="0010 - Disclosure - COMPREHENSIVE LOSS">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_APPAComprehensiveIncomeNoteTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAComprehensiveIncomeNoteTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/DiscontinuedOperations" xlink:title="0011 - Disclosure - DISCONTINUED OPERATIONS">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_APPAAccountingPoliciesAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:label="loc_APPADiscontinuedOperationsPolicyTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPADiscontinuedOperationsPolicyTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/ConvertibleNotesToRelatedParties" xlink:title="0012 - Disclosure - CONVERTIBLE NOTES TO RELATED PARTIES">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_APPADebtDisclosureAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_APPADebtDisclosureTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADebtDisclosureAbstract" xlink:to="loc_APPADebtDisclosureTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/StockholdersEquity" xlink:title="0013 - Disclosure - STOCKHOLDERS' EQUITY">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_APPAStockholdersEquityNoteDisclosureTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/SubsequentEvent" xlink:title="0014 - Disclosure - SUBSEQUENT EVENT">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_APPASubsequentEventsAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_APPASubsequentEventsTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPASubsequentEventsAbstract" xlink:to="loc_APPASubsequentEventsTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/BusinessAndBasisOfPresentationPolicies" xlink:title="0015 - Disclosure - BUSINESS AND BASIS OF PRESENTATION (Policies)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_APPAAccountingPoliciesAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_APPANatureOfOperations"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPANatureOfOperations" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_APPABasisOfAccountingPolicyPolicyTextBlock"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPABasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:label="loc_APPALiquidityDisclosureTextBlock"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPALiquidityDisclosureTextBlock" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_APPASignificantAccountingPoliciesTextBlock"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPASignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_APPANewAccountingPronouncementsPolicyPolicyTextBlock"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPANewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/NetLossPerShareTables" xlink:title="0016 - Disclosure - NET LOSS PER SHARE (Tables)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_APPAEarningsPerShareAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_APPAScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareAbstract" xlink:to="loc_APPAScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/Stock-BasedCompensationTables" xlink:title="0017 - Disclosure - STOCK-BASED COMPENSATION (Tables)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_APPADisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPADisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_APPAScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/DiscontinuedOperationsTables" xlink:title="0018 - Disclosure - DISCONTINUED OPERATIONS (Tables)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_APPAAccountingPoliciesAbstract"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_LossContinuedOperationsTableTextBlock" xlink:label="loc_APPALossContinuedOperationsTableTextBlock"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPALossContinuedOperationsTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/NetLossPerShare-OutstandingPotentiallyDilutiveOptionsWarrantsAndConvertibleNotesDetails" xlink:title="0019 - Disclosure - NET LOSS PER SHARE - Outstanding potentially dilutive options, warrants and convertible notes (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_APPAEarningsPerShareAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_CommonStockUnderlyingConvertibleNotesOutstanding" xlink:label="loc_APPACommonStockUnderlyingConvertibleNotesOutstanding"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEarningsPerShareAbstract" xlink:to="loc_APPACommonStockUnderlyingConvertibleNotesOutstanding" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/Stock-BasedCompensation-Stock-BasedCompensationExpenseDetails" xlink:title="0020 - Disclosure - STOCK-BASED COMPENSATION - Stock-based compensation expense (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_APPAStatementTable"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAStatementTable" order="100"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_APPAStatementLineItems"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAStatementLineItems" order="200"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:label="loc_APPAScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" order="10"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:label="loc_APPAEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="loc_APPAEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" order="0"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_StockBasedCompensationExpenseMember" xlink:label="loc_APPAStockBasedCompensationExpenseMember"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="loc_APPAStockBasedCompensationExpenseMember" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_APPAOperatingExpensesAbstract"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAOperatingExpensesAbstract" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_APPAResearchAndDevelopmentExpense"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAOperatingExpensesAbstract" xlink:to="loc_APPAResearchAndDevelopmentExpense" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_APPAGeneralAndAdministrativeExpense"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAOperatingExpensesAbstract" xlink:to="loc_APPAGeneralAndAdministrativeExpense" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_APPAAllocatedShareBasedCompensationExpense"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAOperatingExpensesAbstract" xlink:to="loc_APPAAllocatedShareBasedCompensationExpense" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_APPAEarningsPerShareBasicAndDiluted"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAOperatingExpensesAbstract" xlink:to="loc_APPAEarningsPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/Stock-BasedCompensation-StockOptionActivityDetails" xlink:title="0021 - Disclosure - STOCK-BASED COMPENSATION - Stock option activity (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_APPAStockIssuedDuringPeriodSharesStockOptionsExercised"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_APPAShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
<link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_APPAShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
<link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
<link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2"/>
<link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_APPASharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
<link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPASharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/DiscontinuedOperations-LossFromDiscontinuedOperationsDetails" xlink:title="0022 - Disclosure - DISCONTINUED OPERATIONS - Loss from discontinued operations (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_APPADiscontinuedOperationsAndDisposalGroupsAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_APPAStatementTable"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_APPAStatementTable" order="100"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_APPAStatementLineItems"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAStatementLineItems" order="200"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_APPAIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_APPADisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_APPADisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_CosmeceuticalAndToiletryBusinessMember" xlink:label="loc_APPACosmeceuticalAndToiletryBusinessMember"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_APPACosmeceuticalAndToiletryBusinessMember" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ChangeInEstimatesGrossProfitGuarantees" xlink:label="loc_APPAChangeInEstimatesGrossProfitGuarantees"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAChangeInEstimatesGrossProfitGuarantees" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/BusinessAndBasisOfPresentationDetailsNarrative" xlink:title="0023 - Disclosure - BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_APPAAccountingPoliciesAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_APPAStatementTable"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPAStatementTable" order="100"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_APPAStatementLineItems"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAStatementLineItems" order="200"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="loc_APPAShareholdersEquityClassAxis"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAShareholdersEquityClassAxis" order="10"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="loc_APPAFairValueByShareholdersEquityClassDomain"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAShareholdersEquityClassAxis" xlink:to="loc_APPAFairValueByShareholdersEquityClassDomain" order="0"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_PrivatePlacement2011Member" xlink:label="loc_APPAPrivatePlacement2011Member"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPAPrivatePlacement2011Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_SecuritiesPurchaseAgreementApril2011Member" xlink:label="loc_APPASecuritiesPurchaseAgreementApril2011Member"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPASecuritiesPurchaseAgreementApril2011Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_PrivatePlacement2012Member" xlink:label="loc_APPAPrivatePlacement2012Member"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPAPrivatePlacement2012Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_APPARetainedEarningsAccumulatedDeficit"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPARetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:label="loc_APPAConvertibleDebtIssuableInConnectionWithPrivatePlacement1"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_APPAProceedsFromConvertibleDebt"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromConvertibleDebt" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ProceedsFromSaleOfUnitsOfCommonStockAndWarrantsNet" xlink:label="loc_APPAProceedsFromSaleOfUnitsOfCommonStockAndWarrantsNet"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromSaleOfUnitsOfCommonStockAndWarrantsNet" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ProceedsFromSaleOfCommonStockNet" xlink:label="loc_APPAProceedsFromSaleOfCommonStockNet"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromSaleOfCommonStockNet" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_APPACashAndCashEquivalentsAtCarryingValue"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPACashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/Stock-BasedCompensationDetailsNarrative" xlink:title="0024 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_APPAStatementTable"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAStatementTable" order="100"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_APPAStatementLineItems"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAStatementLineItems" order="200"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="loc_APPAShareholdersEquityClassAxis"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAShareholdersEquityClassAxis" order="10"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="loc_APPAFairValueByShareholdersEquityClassDomain"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAShareholdersEquityClassAxis" xlink:to="loc_APPAFairValueByShareholdersEquityClassDomain" order="0"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_EmployeeStockPurchasePlan19997Member" xlink:label="loc_APPAEmployeeStockPurchasePlan19997Member"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPAEmployeeStockPurchasePlan19997Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_CommonStockCapitalSharesNumberOfAdditionalSharesReservedForFutureIssuance" xlink:label="loc_APPACommonStockCapitalSharesNumberOfAdditionalSharesReservedForFutureIssuance"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPACommonStockCapitalSharesNumberOfAdditionalSharesReservedForFutureIssuance" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_NumberOfCommonSharesReservedForFutureIssuance" xlink:label="loc_APPANumberOfCommonSharesReservedForFutureIssuance"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPANumberOfCommonSharesReservedForFutureIssuance" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_EmployeeStockPurchasePlanTerms" xlink:label="loc_APPAEmployeeStockPurchasePlanTerms"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAEmployeeStockPurchasePlanTerms" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/ComprehensiveLossDetailsNarrative" xlink:title="0025 - Disclosure - COMPREHENSIVE LOSS (Details Narrative)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_APPAComprehensiveIncomeNetOfTax"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAComprehensiveIncomeNetOfTax" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="0026 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_APPAAccountingPoliciesAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_APPAStatementTable"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAAccountingPoliciesAbstract" xlink:to="loc_APPAStatementTable" order="100"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_APPAStatementLineItems"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAStatementLineItems" order="200"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_APPAIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_APPADisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_APPADisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_CosmeceuticalAndToiletryBusinessMember" xlink:label="loc_APPACosmeceuticalAndToiletryBusinessMember"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_APPACosmeceuticalAndToiletryBusinessMember" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_APPAIncreaseDecreaseInOtherAccruedLiabilities"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GuaranteedBenefitsIncurred" xlink:label="loc_APPAGuaranteedBenefitsIncurred"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAGuaranteedBenefitsIncurred" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/ConvertibleNotesToRelatedPartiesDetailsNarrative" xlink:title="0027 - Disclosure - CONVERTIBLE NOTES TO RELATED PARTIES (Details Narrative)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_APPADebtDisclosureAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_APPAStatementTable"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPADebtDisclosureAbstract" xlink:to="loc_APPAStatementTable" order="100"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_APPAStatementLineItems"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAStatementLineItems" order="200"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ConvertibleDebtAxis" xlink:label="loc_APPAConvertibleDebtAxis"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAConvertibleDebtAxis" order="10"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ConvertibleDebtDomain" xlink:label="loc_APPAConvertibleDebtDomain"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAConvertibleDebtAxis" xlink:to="loc_APPAConvertibleDebtDomain" order="0"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_SecuritiesPurchaseAgreementApril2011Member" xlink:label="loc_APPASecuritiesPurchaseAgreementApril2011Member"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAConvertibleDebtDomain" xlink:to="loc_APPASecuritiesPurchaseAgreementApril2011Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:label="loc_APPAConvertibleDebtIssuableInConnectionWithPrivatePlacement1"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_NotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:label="loc_APPANotesAuthorizedUnderPrivatePlacementInitialClosing"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPANotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_PurchaseOptionUnderPrivatePlacement" xlink:label="loc_APPAPurchaseOptionUnderPrivatePlacement"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAPurchaseOptionUnderPrivatePlacement" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_NumberOfSharesThatCanBePurchasedInExchangeForOneThousandDollarsOfConvertibleNotePrincipalAndAccruedInterest" xlink:label="loc_APPANumberOfSharesThatCanBePurchasedInExchangeForOneThousandDollarsOfConvertibleNotePrincipalAndAccruedInterest"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPANumberOfSharesThatCanBePurchasedInExchangeForOneThousandDollarsOfConvertibleNotePrincipalAndAccruedInterest" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_AmountOfConvertibleDebtPrincipalAndInterestThatCanBeExchangedForTwentyFiveThousandCommonShares" xlink:label="loc_APPAAmountOfConvertibleDebtPrincipalAndInterestThatCanBeExchangedForTwentyFiveThousandCommonShares"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAAmountOfConvertibleDebtPrincipalAndInterestThatCanBeExchangedForTwentyFiveThousandCommonShares" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_APPAProceedsFromIssuanceOfDebt"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromIssuanceOfDebt" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_APPAProceedsFromDebtNetOfIssuanceCosts"/>
<link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_APPADebtInstrumentInterestRateStatedPercentage"/>
<link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPADebtInstrumentInterestRateStatedPercentage" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_APPADebtInstrumentMaturityDate"/>
<link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPADebtInstrumentMaturityDate" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentCallDateEarliest" xlink:label="loc_APPADebtInstrumentCallDateEarliest"/>
<link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPADebtInstrumentCallDateEarliest" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_BeneficialOwnershipAfterConversion" xlink:label="loc_APPABeneficialOwnershipAfterConversion"/>
<link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPABeneficialOwnershipAfterConversion" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotess" xlink:label="loc_APPANoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotess"/>
<link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPANoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotess" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:label="loc_APPACommonSharesRegisteredForResaleInConnectionWithConvertibleNotes"/>
<link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPACommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_TermOfNote" xlink:label="loc_APPATermOfNote"/>
<link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPATermOfNote" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_APPAPaidInKindInterest"/>
<link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAPaidInKindInterest" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_APPAInterestExpenseDebtExcludingAmortization"/>
<link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAInterestExpenseDebtExcludingAmortization" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_APPAAmortizationOfDebtDiscountPremium"/>
<link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:label="loc_APPAConvertibleNotesPayableRelatedPartiesCurrent"/>
<link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAConvertibleNotesPayableRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_APPADebtInstrumentFaceAmount"/>
<link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPADebtInstrumentFaceAmount" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_APPADebtInstrumentUnamortizedDiscount"/>
<link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPADebtInstrumentUnamortizedDiscount" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_CommonStockUnderlyingConvertibleNotesOutstanding" xlink:label="loc_APPACommonStockUnderlyingConvertibleNotesOutstanding"/>
<link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPACommonStockUnderlyingConvertibleNotesOutstanding" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_APPAInterestPayableCurrent"/>
<link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAInterestPayableCurrent" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:type="extended" xlink:role="http://appharma.com/role/StockholdersEquityDetailsNarrative" xlink:title="0028 - Disclosure - STOCKHOLDERS' EQUITY (Details Narrative)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_APPAEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_APPAStatementTable"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAEquityAbstract" xlink:to="loc_APPAStatementTable" order="100"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_APPAStatementLineItems"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAStatementLineItems" order="200"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="loc_APPAShareholdersEquityClassAxis"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementTable" xlink:to="loc_APPAShareholdersEquityClassAxis" order="10"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="loc_APPAFairValueByShareholdersEquityClassDomain"/>
<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAShareholdersEquityClassAxis" xlink:to="loc_APPAFairValueByShareholdersEquityClassDomain" order="0"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_EmployeeStockPurchasePlan19997Member" xlink:label="loc_APPAEmployeeStockPurchasePlan19997Member"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPAEmployeeStockPurchasePlan19997Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_PrivatePlacement2011Member" xlink:label="loc_APPAPrivatePlacement2011Member"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPAPrivatePlacement2011Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_EquityIncentivePlan2007Member" xlink:label="loc_APPAEquityIncentivePlan2007Member"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPAEquityIncentivePlan2007Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_PrivatePlacement2012Member" xlink:label="loc_APPAPrivatePlacement2012Member"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAFairValueByShareholdersEquityClassDomain" xlink:to="loc_APPAPrivatePlacement2012Member" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_APPACommonStockSharesAuthorized"/>
<link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPACommonStockSharesAuthorized" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_APPACommonStockParOrStatedValuePerShare"/>
<link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPACommonStockParOrStatedValuePerShare" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
<link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
<link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_CommonStockCapitalSharesNumberOfAdditionalSharesReservedForFutureIssuance" xlink:label="loc_APPACommonStockCapitalSharesNumberOfAdditionalSharesReservedForFutureIssuance"/>
<link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPACommonStockCapitalSharesNumberOfAdditionalSharesReservedForFutureIssuance" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_APPAProceedsFromIssuanceOfPrivatePlacement"/>
<link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_APPAStockIssuedDuringPeriodSharesNewIssues"/>
<link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_NumberOfUnderlyingCommonSharesRelatingToWarrantsSold" xlink:label="loc_APPANumberOfUnderlyingCommonSharesRelatingToWarrantsSold"/>
<link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPANumberOfUnderlyingCommonSharesRelatingToWarrantsSold" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
<link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_TermsOfPurchasePrivatePlacement" xlink:label="loc_APPATermsOfPurchasePrivatePlacement"/>
<link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPATermsOfPurchasePrivatePlacement" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_TermsOfFailureToKeepAnyRegistrationStatementsContinuouslyEffective" xlink:label="loc_APPATermsOfFailureToKeepAnyRegistrationStatementsContinuouslyEffective"/>
<link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPATermsOfFailureToKeepAnyRegistrationStatementsContinuouslyEffective" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="appa-20130331.xsd#APPA_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:label="loc_APPAProceedsFromIssuanceOfPrivatePlacementNet"/>
<link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromIssuanceOfPrivatePlacementNet" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_APPAPaymentsOfStockIssuanceCosts"/>
<link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAPaymentsOfStockIssuanceCosts" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_APPAProceedsFromWarrantExercises"/>
<link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPAProceedsFromWarrantExercises" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_APPASharePrice"/>
<link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_APPAStatementLineItems" xlink:to="loc_APPASharePrice" xlink:type="arc"/>
</link:presentationLink>
</link:linkbase>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/24  Heron Therapeutics, Inc./DE       10-K       12/31/23   72:10M                                    Donnelley … Solutions/FA
 3/29/23  Heron Therapeutics, Inc./DE       10-K       12/31/22   73:12M                                    Donnelley … Solutions/FA
 2/28/22  Heron Therapeutics, Inc./DE       10-K       12/31/21   74:12M                                    ActiveDisclosure/FA
 2/24/21  Heron Therapeutics, Inc./DE       10-K       12/31/20   74:12M                                    ActiveDisclosure/FA
↑Top
Filing Submission 0001193125-13-213597   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 7:26:42.1pm ET